Direct Effects of PPARα Agonists on Retinal Inflammation and Angiogenesis May Explain How Fenofibrate Lowers Risk of Severe Proliferative Diabetic Retinopathy
Author:
Affiliation:
1. Department of Ophthalmology and Visual Sciences, University of Michigan College of Medicine, Kellogg Eye Center, Ann Arbor, Michigan
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://journals.org/diabetes/diabetes/article-pdf/62/1/36/569450/36.pdf
Reference21 articles.
1. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models;Chen;Diabetes,2013
2. Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial–revisited;Lachin,2008
3. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials;Hemmingsen;BMJ,2011
4. Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus;Wanner,2011
5. Fenofibrate and metabolic syndrome;Kraja;Endocr Metab Immune Disord Drug Targets,2010
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Future Therapeutics: Targeting the NLRP3 Inflammasome Pathway to Manage Diabetic Retinopathy Development and Progression;International Journal of Translational Medicine;2024-06-24
2. Clickable corneal neovascularization therapy with ROS-responsive polydopamine silica nanoparticles loaded with fenofibrate;Materials & Design;2023-11
3. Anti-inflammatory role of fenofibrate in treating diseases;Biomolecules and Biomedicine;2023-01-04
4. Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway;Frontiers in Pharmacology;2022-12-16
5. Fenofibrate Ameliorated Systemic and Retinal Inflammation and Modulated Gut Microbiota in High-Fat Diet-Induced Mice;Frontiers in Cellular and Infection Microbiology;2022-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3